FDA closes out CryoLife warning letter, PerClot trial launches

CryoLife says the FDA closed out a 2013 warning letter sent over problems at a Georgia plant and announces the launch of a clinical trial for its PerClot surgical hemostasis powder.

C.R. Bard, CryoLife, Food & Drug Administration (FDA)

News Well, Clinical Trials, Regulatory/Compliance, Surgical, Warning Letter

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Ij7cOx